07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Since the introduction of environmental, social, and governance ("ESG") investing, the environmental...
Read More >
Employers may be surprised to learn that the Republican-controlled National Labor Relations Board ju...
Read More >
From the initial real estate purchase to completing construction, the entire real estate industry ha...
Read More >
Six months after the onset of the coronavirus pandemic, many merger and acquisition transactions rem...
Read More >
In Seyfarth’s fourth installment in its 2019 Trade Secrets Webinar Series, Seyfarth attorneys Krist...
Read More >
Although the EU has strict rules that limit the circumstances in which Member States can subsidize c...
Read More >